GlobalRPh Renal Dosing Masterv6.6
Source review / handoff

Isoniazid

One or two intact local summaries. No averaged regimen, patient-specific dose or automatic source preference.

Selecting here opens the current stored cards. The pinned link below records their fingerprints. Do not enter patient information in links or searches.

Share or print this source review

1 local source card selected. Local card fingerprints checked where supplied. This is not an original-document hash, source-currency guarantee or clinical approval. Record-level cautions below are the current library's cautions, not a frozen prior version.

Copy is optional; the link can be selected and copied manually. No patient data or dose decision is collected.

Clinical context remains essential

Independent clinical review is pending. Confirm indication, exact formulation/route, population, renal measure and units, kidney-function stability, dialysis prescription, interacting drugs, monitoring and source revision. An RX mirror and its original label are not independent corroboration. Missing disagreement notes do not certify agreement.

The preserved historical tuberculosis treatment descriptions are not presented as an updated TB treatment guideline.

Check source scope before reading a dose

UCSF - isoniazid

Product / population
Adults; source-specific institutional guidance. Match route, indication and renal replacement modality.
Renal method
Qualitative no-adjustment guidance.
Source revision
Revision date not stated in the reviewed page.
Retrieved
2026-09-05
Local review status
Locally included source-specific summary. Regimen differences are not automatically resolved.
Professional

UCSF - isoniazid

Open original reference

UCSF Infectious Diseases Management Program · Adults; source-specific institutional guidance. Match route, indication and renal replacement modality.

Renal method: Qualitative no-adjustment guidance.
Source date: Revision date not stated in the reviewed page.
Retrieved: 2026-09-05

Locally included source-specific summary. Regimen differences are not automatically resolved.

Dosing / renal protocol and limits

The listed adult dose is 300 mg orally daily without routine renal adjustment. During intermittent HD it is given each evening; during continuous HD, 300 mg daily. Select the complete tuberculosis regimen and accompanying monitoring separately.

RDM30-032-isoniazid-1 · Source locator: UCSF - isoniazid; renal/dosing sections and stated qualifiers

Source identity and provenance
Source
https://idmp.ucsf.edu/content/isoniazid
Retrieved
2026-09-05
Renal-function method
Qualitative no-adjustment guidance.
Source date/version
Revision date not stated in the reviewed page.
Hash meaning
Locally authored summary text; not original SPL, HTML or PDF bytes
Local summary SHA-256
8befb8df3d0d85e319c246267c0f207040ed19abebc53b0f0a685a34ee791d38

Document the clinical decision separately

This reference does not select a regimen. Complete the indication, measured/estimated renal function and trend, dialysis setting, source rationale, monitoring and reassessment plan in your institution's approved documentation system. Confirm the complete current source before adopting its regimen.

GlobalRPh v6.6 | RDM66-DIRECT-PHP-20260911 | Local library date 2026-09-11. Selected-card identity does not imply clinical verification.

Pinned reference: https://globalrph.com/blogCalcs/renal-dosing-master/compare.php?id=isoniazid&s1=RDM30-032-isoniazid&h1=1448b96783bf73653dd2ff25d621da59fe3f3649c0a0f1d0cd8bbb15626feecb